Ardelyx Inc reports results for the quarter ended in December - Earnings Summary

Ardelyx

23/02/2024 03:04

* Ardelyx Inc  ARDX.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of 6
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 9 cents per share. Wall Street expected
results to range from -13 cents to -4 cents per share.
    * Revenue fell 22.2% to $34.36 million from a year ago;
analysts
expected $34.23 million. 
    * Ardelyx Inc's reported EPS for the quarter was a loss
of 12
cents​.
    * The company reported a quarterly loss of $28.8 million.
    * Ardelyx Inc shares had risen by 37.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Ardelyx Inc is
$11.75 
This summary was machine generated from LSEG data February 23 at
03:03 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.09          -0.12          Missed
 Sep. 30 2023      -0.11          0.03           Beat
 Jun. 30 2023      -0.11          -0.08          Beat
 Mar. 31 2023      -0.10          -0.13          Missed